Eli Lilly Latest US Company to Commit to Domestic Investments | Global News Avenue

Eli Lilly (Lai) plans to invest at least $27 billion to build four new pharmaceutical sites in the U.S. as the company hopes to increase its domestic drug production amid potential tariff threats.

Eli Lilly, which promises a domestic investment of $23 billion from 2020 to 2024, expects the facilities to be “highly skilled, including engineers, scientists, operations staff and lab technicians”. Workers create more than 3,000 jobs, as well as nearly 10,000 construction industries. The site locations are expected to be announced by the end of this year, and the plants will be launched within five years.

President Trump reportedly said last week that he planned to At least 25% About import of drugs. A few days later, Trump met with medicines privately CEOincluding David Ricks of Eli Lilly and urged them to move manufacturing to the United States Bloomberg.

Eli Lilly shares rose 1% on Wednesday afternoon and have grown about 18% since the beginning of the year.

Apple announced large domestic investment earlier this week

apple(AAPL) said on Monday that it plans to spend more than $500 billion In the next four years, in the United States, including AI The server used to go abroad at a new Texas factory. Apple said it plans to hire about 20,000 people for the Houston factory, and the facility is expected to open in 2026.

Meanwhile, Intel(INTC) has been speculation by Taiwanese semiconductor manufacturing companies. (TSM) Can buy it It struggles with its foundry business, creating a new American chip manufacturing entity with the support of the world’s largest semiconductor manufacturer. These discussions are as vice president JD Vance says The Trump administration hopes to design and manufacture AI chips at home.